Yan Wang, Ph.D., Chief Executive Officer

Dr. Yan Wang has worked in the pharmaceutical industry for more than 20 years. He has been a member of Cytovance’s Board of Directors since 2015, and is also President of Scientific Protein Laboratories, LLC (“SPL”), a pharmaceutical company based in Waunakee, Wisconsin. Prior to his current positions, Yan was Vice President of Business Development and Research at SPL, responsible for business development, product development and M&A activities. Prior to SPL, Yan worked as both a research scientist and a business manager at a specialty chemical company. Yan holds a Ph.D. in Chemistry and an M.B.A., both from the University of Wisconsin-Madison.


Jesse McCool, Ph.D., Chief Technology Officer

Jesse McCool, Ph.D., has over 15 years of experience in microbial process development, process characterization and technology transfer.  Prior to Cytovance, Dr. McCool was the Director of Process Development at Lonza.  In this role he expanded offerings in Microbial R&D Services and improved market presence through driving new technologies development, particularly in the areas of strain development, design-of-experiments (DoE), and late-stage program support.  He helped to adopt a QbD framework for supporting pre-validation activities and supported numerous cGMP campaigns as a subject matter expert.  He also has significant experience in six-sigma and Operational Excellence.   As an established speaker, he has chaired and presented at various industry conferences including Recent Advances in Fermentation Technology, Society for Industrial Microbiology and Biotechnology, Biotechnology Industry Organization, and International Society for Pharmaceutical Engineering.  He has written and contributed to numerous published papers on topics including fermentation process design and microbial expression technologies. 

Dr. McCool holds a Ph.D. in Microbiology from the University of Massachusetts Amherst and completed his postdoctoral studies at the Thayer School of Engineering at Dartmouth College in Hanover, NH working under Professor Tillman U. Gerngross.  Dr. McCool has authored numerous peer-reviewed journal articles and presented throughout his career at many scientific and industry conferences.


Mike O’Mara, Senior Vice President of Manufacturing Operations

Mike O’Mara has more than 23 years’ experience in biopharmaceutical contract manufacturing encompassing microbial, mammalian, and cell therapy manufacturing processes ranging from Preclinical/Phase I through Commercial. Prior to Cytovance, Mike worked at DynPort Vaccine Corporation as Senior Director of Manufacturing, and was TissueGene’s Vice President of Manufacturing, and worked for Lonza Biologics for 18 years in several operations and manufacturing positions. Mike has been part of numerous technology transfers, operational excellence initiatives, FDA and Regulatory agency audits, growing organizations, and manufacturing expansions/build-outs. Mike holds a B.S in Microbiology from The University of Maryland.


Joyce Johnson, M.S.M., Vice President of Human Resources

Joyce Johnson has over 18 years of experience in human resources, most recently serving as the Human Resources Executive at Cimarron Energy. Her responsibilities are improving all Human Resource Management practices and processes, including but not limited to Organizational Development, Talent Acquisition & Retention programs, Shared Services, full life cycle Talent Management, Employee Relations, and Compensation Analysis/Strategy. Joyce holds a Bachelor’s Degree in Psychology and Criminal Justice from Augusta University and an MSM in Human Resources from Troy University.

E.J. Miranda.jpg

Edwin Miranda, Vice President of Quality

Edwin Miranda has over 33 years' of experience in the biopharmaceutical contract manufacturing industry, Edwin brings a depth of experience in quality assurance, encompassing solid & liquid oral dose, biologics and cosmetics. Prior to Cytovance, Edwin oversaw the Quality Assurance team in a successful FDA approval and launch of the New Drug Application (NDA) for Keppra®. He has served as Director of Quality and Vice President of Quality Assurance at URL Mutual Pharmaceuticals, Inc., Legacy Pharmaceutical Packaging, and Piramal Critical Care, Inc. In these roles, he managed the quality systems, oversaw regulatory compliance functions, and developed a successful remediation plan to correct 483 observations, resulting in receipt of an Establishment Inspection Report (EIR) in good standing. Edwin, an army veteran, holds a B.S. in Biology & Chemistry from Angelo State University in San Angelo, TX.


Naomi Seresinhe, M.B.A., Vice President of Program Management

Naomi Seresinhe has over 15 years’ experience in program management – including four years at Cytovance, and four years’ experience in upstream Research and Development. She has experience in process improvement, as well as financial analysis for financial and manufacturing industries. Naomi currently oversees the Program Management Team at Cytovance, and holds a B.Sc. in Microbiology from University of Saskatchewan and an M.B.A. from City University in Washington State.


Lonnie Barish, M.B.A., Vice President of Business Development and Marketing

Lonnie Barish brings over 26 years of experience in sales, marketing and business development. He has worked directly for pharmaceutical/biotech and medical device companies along with service providers that are Contract Manufacturers (CDMO) and Contract Research Organization (CRO). Prior to joining Cytovance, Lonnie worked as the Executive Director, Business Development at WellSpring Pharma Services; Executive Director, North America at Nuvisan Pharma; and Business Development Director at AAIPharma Services to name a few. Lonnie started his career at SmithKline Beecham Pharmaceuticals in Sales and Marketing. Lonnie manages the Marketing, Proposals, and Business Development functions at Cytovance and holds a B.S. in Biologic Sciences and an MBA in Science and Engineering Management from the University of California, Davis.


Matt Hamilton, CPA, Vice President of Finance

Matt Hamilton has over 18 years of experience in Accounting and Finance. Prior to joining Cytovance, Matt served as Corporate Controller for Serva Group, where he oversaw the accounting and finance functions for multiple manufacturing plants. Prior to joining Serva Group, Matt held the position of Plant Controller for Johnson Controls for their Unitary Products Group. Early in Matt’s career, he worked for Bridgestone/Firestone as a Cost Accountant, and he has spent time working in public accounting. Matt manages the Finance, Accounting, AP, and AR functions at Cytovance. Matt holds a B.S degree in Accounting from the University of Oklahoma and is a Certified Public Accountant.